PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

Abroad (travel likely)Recruiting

Conditions

End Stage Renal Disease · Hemodialysis Access Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

  • Sarasota Memorial Health Care System, Sarasota, Florida, United States

  • WakeMed, Raleigh, North Carolina, United States

  • University Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

  • Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas, Texas, United States

  • Houston Methodist Hospital, Houston, Texas, United States

  • Sentara Norfolk General Hospital, Norfolk, Virginia, United States

Study leads
  • Stephen Hohmann, MD

    Principal Investigator

    Baylor Scott and White Health